Dermagraft-TC: Unterschied zwischen den Versionen

Die Seite wurde neu angelegt: „{{NYT en}} right|thumb| '''Dermagraft-TC''' which is an artifical skin created from harvested foreskins from infant circumcision.<ref…“
 
KKeine Bearbeitungszusammenfassung
Zeile 1: Zeile 1:
{{NYT en}}
[[Image:Dermagraft.png|right|thumb|]]
[[Image:Dermagraft.png|right|thumb|]]
'''Dermagraft-TC''' which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb
'''Dermagraft-TC''' ist eine künstliche Haut, die aus geernteten Vorhäuten von Säuglingsbeschneidung hergestellt wird.<ref name='Advanced Biohealing, 2010'>{{REFweb
  |quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
  |quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
  |url=http://www.dermagraft.com/about/overview/
  |url=http://www.dermagraft.com/about/overview/
Zeile 11: Zeile 10:
  |date=
  |date=
  |accessdate=2011-03-06
  |accessdate=2011-03-06
}}</ref> It is made and sold by Advanced Tissue Sciences (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'>{{REFweb
}}</ref> Es wird von [[Advanced Tissue Sciences]] (ATS), einem Unternehmen mit Sitz in La Jolla, CA, hergestellt und verkauft. Dermagraft-TC ist von der FDA zugelassen<ref name='MediLexicon 2011-03-06'>{{REFweb
  |quote=...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
  |quote=...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
  |url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation
  |url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation
Zeile 30: Zeile 29:
  |quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved.
  |quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved.
  |accessdate=2011-03-06
  |accessdate=2011-03-06
}}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>{{REFjournal
}}</ref> und wird für ca. 3.000 US-Dollar pro Quadratfuß (ca. 929 Quadratzentimeter) verkauft, wobei eine Vorhaut genügend genetisches Material enthält, um 250.000 Quadratfuß Haut zu erzeugen.<ref>{{REFjournal
  |last=Daecher
  |last=Daecher
  |first=M.
  |first=M.